Please use this identifier to cite or link to this item: https://doi.org/10.1016/S0090-8258(03)00397-4
Title: Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines
Authors: Rajashekhar, G. 
Loganath, A. 
Roy, A.C. 
Mongelli, J.M. 
Keywords: Apoptosis
Gestational trophoblastic disease
Immunocytochemistry
Metastasis
NJG
Issue Date: 2003
Source: Rajashekhar, G., Loganath, A., Roy, A.C., Mongelli, J.M. (2003). Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines. Gynecologic Oncology 91 (1) : 101-111. ScholarBank@NUS Repository. https://doi.org/10.1016/S0090-8258(03)00397-4
Abstract: Objective. Fas (CD95) is a transmembrane protein of the tumor necrosis factor receptor superfamily that induces apoptosis in susceptible cells on crosslinking by its ligand (FasL). The Fas loss of function and concurrent expression of its ligand (FasL) have been associated with malignant phenotype. In this study, we sought to investigate the hitherto undescribed expression of Fas and FasL on the immortalized human choriocarcinoma cell lines BeWo and NJG. Methods. Receptor and ligand expression was demonstrated using specific antibodies and multiple techniques including immunocytochemistry, confocal immunofluorescence microscopy, flow cytometry, immunoblots, and reverse transcription polymerase chain reaction (RT-PCR). Results. Data from this study indicate that human choriocarcinoma cell subtypes co-express both Fas and FasL. A specific cytoplasmic and membranous pattern of immunoreactivity was noted that was further confirmed at mRNA transcripts by RT-PCR. In addition, we provide evidence using flow cytometry that the Fas receptors are downregulated. The mean fluorescence intensities for NJG and BeWo were 1.47 ± 0.5 and 1.59 ± 0.4, while that for Fas-positive Jurkat cells was 25.6 ± 3.1. Conclusions. To our knowledge, this is the first report on the identification and constitutive co-expression of Fas and FasL in BeWo and NJG choriocarcinoma cells. Choriocarcinoma cells evade immune attack by downregulating the Fas receptor and by killing lymphocytes through expression of FasL. Taken together, our investigations suggest that the Fas/FasL system may represent a mechanism by which malignant trophoblasts become resistant to apoptosis, escape immune surveillance, and metastasize. © 2003 Elsevier Inc. All rights reserved.
Source Title: Gynecologic Oncology
URI: http://scholarbank.nus.edu.sg/handle/10635/36937
ISSN: 00908258
DOI: 10.1016/S0090-8258(03)00397-4
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

10
checked on Dec 11, 2017

WEB OF SCIENCETM
Citations

5
checked on Dec 11, 2017

Page view(s)

80
checked on Dec 9, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.